Chemoinformaics analysis of 1-Fluorododecane
| Molecular Weight | 188.33 | nRot | 10 |
| Heavy Atom Molecular Weight | 163.13 | nRig | 5 |
| Exact Molecular Weight | 188.194 | nRing | 0 |
| Solubility: LogS | -2.92 | nHRing | 0 |
| Solubility: LogP | 3.39 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 37.2668 |
| nHD | 0 | BPOL | 26.1932 |
| QED | 0.418 |
| Synth | 4.027 |
| Natural Product Likeliness | 2.827 |
| NR-PPAR-gamma | 0.032 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.008 |
| HIA | 0.732 |
| CACO-2 | -4.103 |
| MDCK | 0.0000172 |
| BBB | 0.047 |
| PPB | 0.988054 |
| VDSS | 1.669 |
| FU | 0.0145565 |
| CYP1A2-inh | 0.595 |
| CYP1A2-sub | 0.136 |
| CYP2c19-inh | 0.955 |
| CYP2c19-sub | 0.66 |
| CYP2c9-inh | 0.901 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.692 |
| CYP2d6-sub | 0.511 |
| CYP3a4-inh | 0.899 |
| CYP3a4-sub | 0.496 |
| CL | 8.939 |
| T12 | 0.455 |
| hERG | 0.084 |
| Ames | 0.77 |
| ROA | 0.901 |
| SkinSen | 0.983 |
| Carcinogencity | 0.54 |
| EI | 0.88 |
| Respiratory | 0.814 |
| NR-Aromatase | 0.912 |
| Antiviral | No |
| Prediction | 0.505267 |